Public Company News

CStone announces the registrational clinical study results of sugemalimab in stage IV non-small cell lung cancer published in The Lancet Oncology

SUZHOU, China, Jan. 15, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that results of the GEMSTONE-302...

2022-01-15 08:31 6433

Mycronic receives order for an SLX mask writer

STOCKHOLM, Jan. 14, 2022 /PRNewswire/ -- Mycronic AB (publ) has received an order for an SLX mask writer from a new customer inAsia. The order value is in the range ofUSD 3-5 million. Delivery of the system is planned for the second quarter of 2022. The SLX laser mask writer meets rising demand ...

2022-01-14 21:28 4909

XCMG Delivers Concrete Mixing Machinery to Thailand as One of China's First Approved RCEP Exporters

XUZHOU, China, Jan. 14, 2022 /PRNewswire/ -- XCMG Import & Export Company Co., Ltd. has been approved by Nanjing Customs as one ofChina's first approved RCEP exporters and named asChina's first declaration of origin for the export of a concrete mixing truck toThailand. The implementation of "app...

2022-01-14 20:20 7083

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced tha...

2022-01-14 19:18 3799

Crunchfish Gesture Interaction introduction - Deeply intuitive gestures

STOCKHOLM, Jan. 14, 2022 /PRNewswire/ -- Crunchfish develops AI technology for gesture interaction with exceptional performance, optimized for augmented and virtual reality (AR/VR), automotive and the next generation digital interfaces. An introduction to gesture Interaction was the topic of the ...

2022-01-14 19:17 3377

ZTO Held 2022 Nationwide Network Conference

SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- On January 13, 2022 local time, ZTO Express (Cayman) Inc. (NYSE: ZTO; HKEX: 2057) ("ZTO" or the "Company"), a leading and fast-growing express delivery company inChina, held its 2022 Nationwide Network Conference inShanghai. In 2021, ZTO delivered 22.3 b...

2022-01-14 17:30 9079

GWM Hit a New Record in 2021 with 15% Sales Growth

BAODING, China, Jan. 14, 2022 /PRNewswire/ -- GWM released the latest sales data onJanuary 6 that the company registered a volume of nearly 1.3 million vehicles in 2021, up 15.2% year-on-year, which marks the new record that the sales have been more than one million units for six consecutive year...

2022-01-14 13:02 12276

Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide

SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), andSingapore's Experimental Drug Development Centre ("EDDC") today announced a global licensing agreement under which Everest will obtain exclusive...

2022-01-14 08:00 6499

The Future of the Point of Sale is Here: Visa Pioneers Cloud-Based Payment Acceptance

* Visa Acceptance Cloud creates more seamless, affordable point of sale opportunities for small businesses, retailers, fintechs, and the businesses that support them  SYDNEY, Jan. 14, 2022 /PRNewswire/ -- Today Visa (NYSE: V) announced a new platform, Visa Acceptance Cloud (VAC), set to revolut...

2022-01-14 05:00 7061

Marioff Strengthens Long-Standing Partnership with Carnival Corporation & PLC

VANTAA, Finland, Jan. 13, 2022 /PRNewswire/ -- Marioff has extended its BluEdge ™ Elite service agreement with Carnival Corporation & PLC for an additional five years to provide preventive maintenance services for its HI-FOG® water mist fire protection systems, currently installed aboard 75 cruise...

2022-01-13 21:05 5096

IPS Expands Long Haul Submarine Data Transmission Capacity with Ribbon's IP Optical Solutions

Leverages Apollo optical transport solutions for high capacity service connections under the South China Sea with links exceeding 2,500 km (1,500 miles) PLANO, Texas, Jan. 13, 2022 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software a...

2022-01-13 21:00 3283

Retail Industry Reshapes with Hybrid Cloud and AI to Help Meet Shifting Consumer Shopping and Sustainability Preferences

2022 IBM/NRF global consumer study finds: - 'Hybrid shopping' is the method of choice for over one in four consumers surveyed - 62% of consumers surveyed are willing to change their purchasing habits to reduce environmental impact, but intention/action gap remains ARMONK, N.Y., Jan. 13, 2022 /P...

2022-01-13 21:00 3740

Mindtree Reports Strong Performance in Q3 FY22

BANGALORE, India and WARREN, N.J., Jan. 13, 2022 /PRNewswire/ -- Mindtree , a global technology services and digital transformation company, announced its consolidated results today for the third quarter endedDecember 31, 2021, as approved by its Board of directors. "We...

2022-01-13 19:50 4010

Veoneer's Research Tech Talk "Trust in Collaborative - and Self-Driving - What's Next?" Published Virtually

STOCKHOLM, Jan. 13, 2022 /PRNewswire/ -- The automotive technology company Veoneer, Inc.(NYSE: VNE) (SSE: VNE SDB), has published its 2022 Research Tech Talk, "Trust in Collaborative - and Self-Driving - What's Next?", where thought leaders discuss the power and potential of the expanding world o...

2022-01-13 17:54 3298

Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne

HANGZHOU and SHAOXING, China, Jan. 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC40 for moderate to severe acne. ASC40 is an oral, selective inhibitor of fatty acid synthase (FASN), a key enzyme whic...

2022-01-13 17:30 5024

HeiQ Launches World's First Dual Action Textile Cooling Technology

ZÜRICH, Jan. 13, 2022 /PRNewswire/ -- HeiQ announces the launch of a new dual action textile cooling technology, HeiQ Cool, the world's first textile technology to deliver both instant contact cooling and continuous evaporative cooling.

2022-01-13 17:00 5105

Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046

* Interim analysis expected in the second quarter of 2022 SUZHOU, China, Jan. 13, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase II clinical study of KN026 (HER2 bispecific antibody) combined with KN046 (PD-L1/CTLA-4 bispecific antibody) (KN026-203) has su...

2022-01-13 10:46 4033

CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)

* Sugemalimab has the potential to become the world's first immunotherapy to be approved for patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) * The National Medical Products Administration (NMPA) of China has granted the Breakthrough Therapy Designati...

2022-01-13 08:05 7925

Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference

SEOUL, South Korea, Jan. 13, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a presentation at the 40th annual J.P. Morgan Healthcare virtual Conference. Dr.Jong-Yoon Chun, CEO of Seegene...

2022-01-13 04:00 3920

Infosys: Revenue guidance for FY22 revised upwards to 19.5%-20.0%, powered by sequential growth of 7.0% in Q3

BENGALURU, India, Jan. 12, 2022 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong Q3 performance with sequential growth of 7.0% in a seasonally weak quarter and year-on-year growth of 21.5% in constan...

2022-01-12 20:53 10504
1 ... 855856857858859860861 ... 903